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Abstract
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Background—The association between institutional volume and outcomes has been
demonstrated for cardiac catheterization among adults, but less is known about this relationship
for patients with congenital heart disease (CHD) undergoing cardiac catheterization.
Methods—Within the IMPACT® (Improving Pediatric and Adult Congenital Treatment)
Registry, we identified all catheterizations between January 2011 and March 2015. Hierarchical
logistic regression, adjusted for patient and procedural characteristics, was used to determine the
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association between annual catheterization lab volume and occurrence of a major adverse event
(MAE).
Results—Of 56,453 catheterizations at 77 hospitals, an MAE occurred in 1,014 (1.8%) of cases.
In unadjusted analysis, an MAE occurred in 2.8% (123/4,460) of cases at low-volume hospitals
(<150 procedures annually), as compared with 1.5% (198/12,787), 2.0% (431/21,391), and 1.5%
(262/17,815) of cases at medium- (150-299 annual procedures), high- (300-499 annual
procedures), and very high-volume (≥500 procedures annually) hospitals, respectively, p<0.001.
After multivariable adjustment, this significant relationship between annual procedure volume and
occurrence of an MAE persisted. Compared to low-volume programs, the odds of an MAE was
0.55 (95% confidence interval [CI] 0.35, 0.86, p=0.008), 0.62 (95% CI 0.41, 0.95, p=0.03), and
0.52 (95% CI 0.31, 0.90, p=0.02) at medium-, high-, and very high-volume programs, respectively.

Author Manuscript

Conclusions—Although the risk of MAE after cardiac catheterization in patients with CHD is
low at all hospitals, it is higher among hospitals with fewer than 150 cases annually. These results
support the notion that centers meeting this threshold volume for congenital cardiac
catheterizations may achieve improved patient outcomes.
Keywords
congenital heart disease; cardiac catheterization
The relationship between institutional procedural volume and clinical outcomes has been
described for several cardiovascular procedures, including coronary revascularization
procedures and placement of implantable cardioverter defibrillators (ICDs)(1,2). This
“volume-outcome” relationship extends to the field of pediatric cardiovascular surgery, with
higher peri-procedural mortality rates at low-volume programs(3-10).
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Less is known regarding the relationship between institutional procedural volume and
occurrence of adverse events among pediatric and adult patients with congenital heart
disease (CHD) undergoing cardiac catheterization. Prior work has suggested an association
between operator-level experience and incidence of adverse events, suggesting that
individual interventionalists undergo a “learning curve”(11). Moreover, a recent study
evaluating the relationship between institutional volume and catastrophic adverse events in
children and young adults undergoing cardiac catheterization found a reduced risk of
catastrophic events at higher volume centers(12). However, this study was performed using
administrative data, in which limited clinical detail makes adjustment for patient- and
procedural-level variables challenging. Therefore, the relationship between institutional
volume and outcomes for cardiac catheterization in pediatric and adult patients with CHD is
less well-defined.
The NCDR's (National Cardiovascular Data Registry) IMPACT® (IMproving Pediatric and
Adult Congenital Treatment) Registry is the largest clinical registry, to date, of percutaneous
CHD procedures. The registry collects information on pediatric patients with congenital or
acquired heart disease and adult patients with CHD undergoing diagnostic and interventional
cardiac catheterization procedures(13). As a result, IMPACT has both the size and clinical
detail to evaluate the relationship between institutional procedural volume and the
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occurrence of adverse events with appropriate adjustment for patient- and procedure-level
factors. The goal of this project was to examine whether hospitals performing more cardiac
catheterizations on pediatric or adult patients with CHD experience fewer major adverse
events as compared with hospitals performing lower volumes of similar procedures.

Methods
Study Population

Author Manuscript

IMPACT is a U.S.-based registry collecting information on pediatric and adult patients with
CHD undergoing diagnostic or interventional cardiac catheterization. Details regarding
registry development and its basic design have been previously published(13). In brief,
centers performing cardiac catheterization on pediatric patients with congenital or acquired
heart disease and adult patients with CHD are eligible for voluntary enrollment in IMPACT.
Participating centers collect detailed information on all consecutive patients undergoing a
catheterization procedure, including information regarding patient demographics, clinical
data, and detailed procedural information. IMPACT uses standardized data elements and
definitions and is subject to rigorous quality assurance standards. The current study used
data from IMPACT v1.0.1. A comprehensive description of the IMPACT Registry data
elements and definitions is available at: https://www.ncdr.com/WebNCDR/impact/home/
datacollection.
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From January 2011 through March 2015, a total of 57,032 diagnostic or interventional
cardiac catheterization procedures at 77 US centers were identified. Procedures that could
not be assigned to a procedural risk group (n=14)(14), had missing information regarding
single ventricle status (n=217), or had missing data on adverse events (n=348) were
excluded. The final study cohort comprised 56,453 cardiac catheterization procedures
(52,295 episodes of care) at 77 centers.
Study Outcome

Author Manuscript

The primary outcome was the occurrence of a major adverse event, defined as occurrence of
any of the following: cardiac arrest; arrhythmia requiring permanent pacemaker; cardiac
tamponade (requiring pericardial drainage); air embolus; embolic stroke within 72 hours of
the cardiac catheterization; new requirement for dialysis, extracorporeal membrane
oxygenation (ECMO), or left ventricular assist device (LVAD); unplanned cardiac, vascular,
or other surgery (due to catheterization complication); or subsequent cardiac catheterization
(due to catheterization complication). Unless otherwise specified, adverse events are coded
up to 30 days following the catheterization procedure, aside from unplanned surgery and
subsequent cardiac catheterization which are coded until the time of hospital discharge.
Death was excluded from the primary outcome because death during the hospitalization
cannot definitively be attributed to cardiac catheterization and could have resulted from
other in-hospital events (e.g. cardiac surgery)(15). As a secondary outcome, however, death
was added to the primary outcome described above.
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Annual procedure volume was calculated based upon the number of cases submitted during
the study period divided by the number of months a center submitted data to IMPACT
multiplied by 12. This was chosen over individual annual catheterization volume because it
was felt that the experience of an individual center was durable and unlikely to be prone to
year-to-year variation. Centers were categorized into four groups based upon annual
procedural volume: low-volume (<150 cases per year), medium-volume (150-299 cases per
year), high-volume (300-499 cases per year), and very high-volume (≥500 cases per year).
These cut-points were defined a priori, and roughly correlated with quartiles of hospitals’
volumes (Figure 1).
Patient and Procedural Risk Factors

Author Manuscript

We adjusted for a number of pre-defined patient and procedural risk factors to account for
center differences in case-mix. These included age at the time of cardiac catheterization
(categorized as neonates [<30 days], infants [≥30 days to ≤1 year], children [1≤18 years],
and adults [>18 years of age]) and procedure status (elective, urgent, emergent, or salvage).
We also adjusted for pre-procedure sepsis and patients’ requirement for inotrope therapy,
ECMO, or LVAD prior to the procedure. Additionally, we adjusted for medical comorbidities (chronic lung disease and renal insufficiency), single ventricle physiology, and
the presence of a genetic or congenital condition (i.e. 22q11 deletion, Alagille syndrome,
congenital diaphragmatic hernia, Trisomy-21, heterotaxy syndrome, Marfan syndrome,
Noonan syndrome, Rubella, Trisomy-13, Trisomy-18, Turner syndrome, Williams-Beuren
syndrome).
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We also sought to adjust for severity of illness in our model, using the concept of
hemodynamic vulnerability. Hemodynamic vulnerability was determined using previously
published data from the Congenital Cardiac Catheterization Project on Outcomes (C3PO), a
collaboration of eight centers collecting data on catheterization procedures performed for
congenital heart disease(16). In brief, four hemodynamic variables (systemic ventricular end
diastolic pressure, systemic arterial saturation, mixed venous saturation, and main
pulmonary artery pressure) are known to be independently associated with experiencing a
high-severity adverse event following cardiac catheterization and are used to classify a
patient as hemodynamically vulnerable. Thresholds for each variable differ based upon
whether a patient has single or 2-ventricle physiology and specifically are: 1) systemic
arterial saturation <95% in 2-ventricle and <78% in single-ventricle patients; 2) mixed
venous saturation <60% in 2-ventricle and <50% in single-ventricle patients; 3) main
pulmonary artery systolic pressure ≥45mmHg in 2-ventricle patients and a main pulmonary
artery mean pressure ≥17mmHg in single-ventricle patients; and 4) a systemic ventricular
end diastolic pressure ≥18mmHg (regardless of underlying anatomy). For each variable,
patients were classified as “yes” if their catheterization procedure met criteria for
hemodynamic vulnerability, “no” if their catheterization data did not meet criteria for
hemodynamic vulnerability, or “missing” if data were missing on the relevant hemodynamic
parameter. This third category of “missing” was used given that the reasons for missing data
were not known and exclusion of records with missing hemodynamic data had the potential
to result in model bias. For example, it was unknown whether patients missing
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hemodynamic data were patients for whom the particular hemodynamic variable was not
relevant or whether they were critically ill patients whose clinical status precluded a
thorough hemodynamic assessment. In total, there were 5,285 (9.4%) records missing data
on systemic arterial saturation, 7,500 (13.3%) records with missing data on mixed venous
saturation, 20,728 (36.7%) records missing data on systemic ventricle end diastolic pressure,
and 15,268 (27.0%) records with missing data on main pulmonary artery pressures.

Author Manuscript

We also adjusted for procedural risk factors, including procedure-type risk group. To do this
we utilized procedure risk groups previously derived from C3PO data (14) (Table 1). Briefly,
congenital cardiac catheterization encompasses a wide variety of interventional procedure
types, each associated with different degrees of risk. Given the broad range of procedure
types, adjustment for each individual procedure is not feasible. Procedure-type risk
categories were developed to overcome this issue and to establish a classification system
whereby procedures of similar risk are grouped. Within C3PO, four categories of procedural
risk were created and validated (Category 1= procedures associated with lowest risk vs.
Category 4= procedures associated with highest risk). The risk groups were derived using a
combination of empirically derived data and expert consensus and were found to have good
discrimination between each of the categories. For catheterization lab visits where more than
one procedure was performed, the case was categorized according to the procedure of
highest risk.
Statistical Analysis

Author Manuscript

Baseline patient characteristics for low-, medium-, high-, and very high-volume programs
were compared using one-way analysis of variance for continuous variables and chi-square
or Fisher's exact test for categorical variables. Within the study population, there were a
small number of patients missing data on one of the relevant covariates (excluding those
with missing hemodynamic data as detailed above). In total, 3.4% of patients were missing
data for at least one covariate. Only 0.38% of patients were missing data for more than one
covariate. Data were imputed using IVEware software (University of Michigan, Ann Arbor,
MI), aside from the missing hemodynamic data which were handled as described above.
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A multivariable hierarchical logistic regression model that adjusted for patient and
procedural characteristics (as described above) was used to evaluate the association between
annual hospital volume and occurrence of a major adverse event. Covariates (listed above)
were selected based on clinical relevance and previously published literature. All covariates
were included in the final model, regardless of statistical significance. A hierarchical model
was used to account for nesting of patients within hospitals. In these multivariable analyses,
hospitals were modeled as random effects whereas patient and procedural factors were
modeled as fixed effects. Moreover, to identify whether or not the association between
institutional volume and occurrence of adverse events differed based upon procedural risk or
based upon age, a hospital volume-by-procedure-risk-group interaction and a hospital
volume-by-age interaction were examined. The primary model treated hospital volume as a
categorical variable. A second analysis was performed treating hospital volumes as a
continuous variable, after first testing for a non-linear association using restricted cubic
splines. If no non-linear association was detected, volume was treated as a linear continuous
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variable. A similar analytic approach was used for the secondary outcome, wherein death
was included as part of the composite end point. All analyses were evaluated using 2-sided
tests of significance with a threshold of p<0.05. Analyses were performed with SAS 9.3
(SAS Institute, Cary, NC) or R version 2.11.1(17). The study was conducted on de-identified
quality improvement registry data and did not meet criteria for requirement of informed
consent. The IMPACT Registry's Research and Publications Committee approved the final
manuscript draft. Dr. Jayaram was supported by a T32 training grant (HL110837) from the
National Heart Lung and Blood Institute. Dr. O'Byrne received support from the NIH [T32
HL007915] and Entelligence Young Investigator grant. Dr. Chan is supported by an R01
Award (1R01HL123980) from the National Heart Lung and Blood Institute. The authors are
solely responsible for the design and conduct of this study, all study analyses, the drafting
and editing of the paper and its final contents.
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Results
The mean annual case volume per hospital was 286± 214, and the median annual case
volume was 240 (inter-quartile range: 130 to 387; total range: 24 to 1233) (Figure 1).
Among the 77 hospitals, 24 (31.2% of hospitals and 7.9% of cases) were low-volume
centers, 22 (28.6% of hospitals and 22.7% of cases) medium-sized centers, 23 (29.9% of
hospitals and 37.9% of cases) high-volume centers, and 8 (10.4% of hospitals and 31.6% of
cases) very high-volume centers.

Author Manuscript

Of the 56,453 cardiac catheterization cases, the majority were performed in patients under
18 years of age, with 3,457 (6.1%) in neonates, 11,108 (19.7%) in infants, and 33,464
(59.3%) in children, whereas 8,424 (14.9%) were performed in adults. Patient and
procedural characteristic by the four hospital categories of procedural volume are
summarized in Tables 2 and 3. Low-volume-programs had a higher proportion of adult
patients compared to larger-sized programs. Low-volume programs also had a smaller
percentage of single ventricle patients. Genetic conditions were slightly more prevalent at
very-high volume programs. Low-volume programs had a smaller percentage of their
patients undergoing procedures classified within the highest procedural risk group. Veryhigh volume programs were more likely to have cases scheduled as urgent procedures and
less likely to have procedures scheduled electively.

Author Manuscript

Overall, there were 1,014 major adverse events, with an overall rate of 1.8%. The most
common adverse events were cardiac arrest (0.7%), unplanned cardiac surgery (0.4%), and
subsequent cardiac catheterization due to a complication during the initial cardiac
catheterization procedure (0.4%). In unadjusted analysis, major adverse events differed
based upon annual institutional volume, with a major adverse event occurring in 123 (2.8%)
cases at low-volume hospitals, 198 (1.5%) cases at medium-volume hospitals, 431 (2.0%)
cases at high-volume hospitals, and 262 (1.5%) cases at very high-volume hospitals
(p<0.001) (Table 4)(Figure 2).
After adjusting for patient and procedural characteristics, the difference in rates of major
adverse events by hospital procedural volume persisted. Compared with low-volume centers,
the odds of an adverse event was 0.55 (95% confidence interval [CI]: 0.35, 0.86, p=0.008),
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0.62 (95% CI: 0.41, 0.95, p=0.03), and 0.52 (95% CI: 0.31, 0.90, p=0.02) at medium-, high-,
and very high-volume centers, respectively (Table 5). To further investigate the relationship
between annual hospital volume and occurrence of a major adverse event, annual hospital
volume was also treated as a continuous variable. Testing for a non-linear relationship using
a 3-knot spline term was non-significant (p=0.96), therefore annual volume was modeled as
a linear term. The relationship between annual hospital volume and occurrence of a major
adverse event when modeling annual volume as a continuous variable became nonsignificant (odds ratio 0.94 [95% CI=0.88, 1.02] per increase in annual volume of 100
patients, p=0.13). A procedure-type risk group and hospital annual volume interaction
demonstrated that the relationship between annual volume and occurrence of adverse events
was no different for low-risk as compared with high-risk procedures (p=0.53). Likewise, an
age and hospital annual volume interaction demonstrated that the relationship between
annual volume and occurrence of adverse events was no different for adults (≥18 years of
age) as compared with non-adults (<18 years of age) (p=0.87).

Author Manuscript

As a secondary analysis, the association between annual hospital volume and occurrence of
an adverse event was evaluated with in-hospital death included in the composite outcome.
The overall rate of death during the index hospitalization was 1.5% (800/52,295 episodes of
care), and this rate was similar at low-volume (61/4,332 [1.4%]), medium volume
(185/11,974 [1.5%]), high-volume (315/19,882 [1.6%]), and very high-volume centers
(239/16,107 [1.5%]; p-value for difference across the 4 hospital volume categories of 0.79).
In unadjusted analysis, the rate of major adverse events (including death) differed by annual
institutional volume: low-volume centers (153/4,332; 3.5%), medium-volume centers
(353/11,974; 2.9%), high-volume centers (556/19,982; 2.8%), and very high-volume centers
(410/16,107; 2.5%) (p=0.004). No association was observed between annual hospital
procedural volume and occurrence of an adverse event (when death was included) after
multivariable adjustment regardless of whether volume was treated as a categorical (p=0.29)
(Table 4) or continuous variable (odds ratio 0.96 [95% CI=0.92, 1.01] per increase in annual
volume of 100, p=0.16)

Discussion

Author Manuscript

In a large multicenter registry of cardiac procedures among pediatric and adult patients with
CHD, we found that cardiac catheterization procedures were generally safe with overall
peri-procedural rates of major adverse events of less than 2%. Despite the low rate, the
adjusted odds of a major adverse event peri-procedurally, when excluding death, were 38%
to 48% lower at hospitals with annual case volumes exceeding 150 cardiac catheterization
procedures. While the absolute differences were small, these data suggest a small volumeoutcome relationship for cardiac catheterization procedures among pediatric and adult
patients with CHD, although this relationship was not observed when death was included as
a major adverse event.
The concept of a “volume-outcome” relationship has been evaluated in several clinical
settings, including cardiovascular procedures. For instance, a prior study of complications
related to ICD implantation has reported an inverse relationship between occurrence of an
adverse event and annual procedural volume(1). A similar inverse relationship was found
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between hospital procedure volume and outcomes following percutaneous coronary
intervention(2). Within the pediatric literature, a relationship has been demonstrated for
cardiac surgery with higher peri-procedural mortality at hospitals performing fewer cardiac
surgeries(3-10). Interestingly, this relationship seems to be most relevant for highcomplexity procedures(3).

Author Manuscript

Studies on the relationship between procedural volume and adverse events for patients with
CHD undergoing cardiac catheterization, on the other hand, have been few. In a study using
data from Congenital Cardiac Catheterization Project on Outcomes (C3PO), the authors
found that operators with less overall experience (<5 years in practice) were more likely to
experience an adverse event compared with operators with 5-25 years in practice (11). In a
more recent study involving data on cardiac catheterization procedures within the Pediatric
Health Information Systems (PHIS) database, an inverse relationship between annual
institutional volume and risk of death or need for mechanical circulatory support in the
immediate post-catheterization period was reported(12). While an important finding, this
study was performed using administrative data with limited detail about patient- (e.g.
hemodynamic data) and procedure-level (e.g. specific interventional procedure) factors,
which limits the degree to which risk stratification could be performed. Additionally, the
ability to include more granular data regarding procedural outcomes was lacking, given the
administrative data source.

Author Manuscript

A relationship between hospital volume and outcomes has important implications within the
health care system. If higher-volume hospitals do, in fact, have improved outcomes, patients
with CHD may be able to make more informed decisions about where to obtain invasive
diagnostic or interventional cardiac procedures. Organizations such as the Leapfrog group
promote the transparent reporting of quality and outcomes within the healthcare system and
have proposed creating volume-standards for certain types of high-risk surgical procedures
(18). Our study is one of the first to describe the relationship between volume and outcomes
for congenital cardiac catheterization and suggests that the risk of cardiac catheterization for
pediatric and adult patients with CHD may be slightly higher at centers performing fewer
than 150 procedures annually. Interestingly, this same institutional procedural volume
threshold has been previously put forth in a number of opinion-based consensus statements
related to performance of higher complexity procedures and training in pediatric cardiac
catheterization(19-21).

Author Manuscript

In our study, medium-, high-, and very high-volume centers were less likely to experience a
major adverse event as compared with low-volume centers. However, despite this
statistically significant categorical association between volume and outcomes, the low event
rate translates into small absolute differences in rates of major adverse events between lowvolume and higher-volume centers. Additionally, we see a significant amount of variability
in risk even within volume categories (particularly among low-volume centers), indicating
that center volume alone does not explain all of the variability in outcomes between
institutions. For these reasons, it would be difficult to make definitive recommendations
regarding regionalization of care for these procedures based solely on our study findings.
Rather, the findings of our study should be considered along with other factors, including
patient need and preference. Patients with CHD in need of a cardiac catheterization may
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prefer to seek care closer to home, particularly if they can do so with only a small increased
risk from local treatment. Additionally, selective referral to high-volume centers can create
unnecessary barriers to care for patients with limited resources needing to travel to a highervolume center and can create delays in care for patients in need of immediate treatment.
Without a more robust difference in outcome based upon center volume, each of these
factors must be carefully considered before selectively referring a patient to another hospital
based solely on center volume. Furthermore, while we found a small difference in outcomes
based upon center volume, we were unable to determine the reason for lower rates of major
adverse events at higher volume centers. While it is possible that improved outcomes are an
inextricable benefit of more procedural experience, it is also possible that there are learned
best practices at higher volume centers. If these best practices could be transmitted to all
centers, it could also obviate the need for selective referral based upon center volume.
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Despite finding a significant categorical association between volume and outcomes, we did
not find a statistically significant relationship between volume and outcomes when modeling
volume continuously. Intuitively, this finding makes sense as the volume-outcome
relationship is unlikely to be linear, at least not along all points of the volume spectrum. As
an example, it is likely that increasing annual center volume from 25 to 125 procedures
would result in a larger effect on patient outcomes than an increase in annual center volume
from 1000 to 1100 procedures, even though this difference would be treated the same in a
linear model of center volume. Instead, our results suggest that there may be a “critical
mass” needed in order to achieve similar outcomes. In fact, when comparing outcomes
between small volume programs (<150 cases/year) and all other centers, we found that
centers performing more than 150 cases annually were less likely to experience an adverse
event (OR 0.57, 95% CI 0.40, 0.84, p=0.004).
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Additionally, in our study, we did not find a significant relationship between volume and
outcomes in our secondary analysis, when in-hospital death was included as a component of
the composite end point. It is important to note that the definition of “death” in the current
version of IMPACT includes death that occurred at any time following cardiac
catheterization and prior to hospital discharge, without adjudication regarding attribution to
the catheterization. As such, mortality events may represent the illness severity of patients
and may not be secondary to their cardiac catheterization procedure. Indeed, a prior study
found that 30-day mortality in patients with CHD undergoing cardiac catheterization is
unlikely to be related to the cardiac catheterization procedure but rather to pre-procedural
morbidity, subsequent in-hospital events, or non-cardiac causes(15). Furthermore, in the
prior study evaluating the relationship between volume and outcomes in the PHIS database,
the association between center volume and risk of catastrophic adverse events was evident in
the immediate post-catheterization period, however, when the timeline for follow-up was
extended until hospital discharge, the relationship between volume and outcomes was less
clear. The lack of association between volume and outcomes when death is included in the
composite end point, in our study, suggests that death within a certain timeframe following
catheterization or death with some adjudication regarding cause, may be the most suitable
marker of catheterization-related quality of care.
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Our findings should be interpreted in the context of the following potential limitations. First,
we did not evaluate the relationship between individual operator volume and adverse events.
Institutional volume and operator volume might be independently related to adverse event
rates but are also likely to be collinear. This complicated relationships will need to be
evaluated in future studies. Second, while we presumed that the occurrence of a major
adverse event was directly related to the cardiac catheterization, we cannot rule out the
possibility that the adverse event may have been unrelated to the catheterization procedure.
This is particularly germane to the occurrence of death, which we presumed was not related
to the percutaneous procedure and included it only as a secondary analysis. Future data
collection efforts for IMPACT should seek to discriminate between deaths attributable to
cardiac catheterization procedures and other complications of care. Third, while some
institutions may restrict coding of major adverse events to complications that are directly
linked to the cardiac catheterization, other institutions may code any in-hospital adverse
event, regardless of direct linkage to the catheterization. Differences in reporting of
complication rates among hospitals could thus have influenced our study findings, especially
if they systematically varied by hospital volume. Given that IMPACT is a relatively new
registry with no publicly available data audits, results from future data audits should be
evaluated to ensure that data reporting is consistent between institutions and that institutions
are appropriately attributing adverse events during the data reporting process. Lastly, our
study was an observational study and is subject to the same limitations as all observational
studies, including the possibility of unmeasured confounding. For example, low-volume
centers had a higher proportion of adult patients. While we adjusted for age in our
multivariable analysis, there may be other characteristics unique to adults that we did not
adjust for.

Author Manuscript

Conclusions
Using a large multicenter registry, we found that centers performing at least 150 cardiac
catheterizations on pediatric and adult patients with CHD had a numerically small but
statistically significantly lower rate of adverse events as compared with low-volume centers.
Our findings provide some support for regionalizing care at centers performing more than
150 cases per year, but other issues of access to care and patient preference will also need to
be considered.
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implantable cardioverter defibrillator

CHD

congenital heart disease

NCDR

National Cardiovascular Data Registry

IMPACT

Improving Pediatric and Adult Congenital Treatment

ECMO

Extracorporeal membrane oxygenation
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Left Ventricular Assist Device
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Congenital Cardiac Catheterization Project on Outcomes
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confidence interval
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Figure 1.

Annual Center Volume. Annual case volume for each of the 77 participating centers.
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Figure 2.

Unadjusted major adverse event rate (excluding death) based upon annual catheterization
volume. Triangle represents mean and dark bar represents median rate. Adverse event rates
are lower at medium, high, and very-high volume centers although variability within center
volume exists, particularly for low-volume centers.
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Procedure-Type Risk Categories

Author Manuscript

Risk Category 1

Risk Category 2

Risk Category 3

Age ≥1 year

Age ≥1 month <1 year

Age <1 month

Pulmonary valve ≥1 month

Aortic valve ≥1 month
Pulmonary valve <1 month
Tricuspid valve

Aortic valve <1 month
Mitral valve

ASD/PFO
PDA
Fontan fenestration
Systemic to pulmonary
artery collaterals

Systemic surgical shunt
Baffle leak
Coronary fistula

VSD
Perivalvar leak

Balloon angioplasty

RVOT
Aorta dilation <8atm

Pulmonary artery < 4 vessels
Pulmonary artery ≥ 4 vessels
all <8atm
Aorta >8atm or CB
Systemic artery (not aorta)
Systemic surgical shunt
Systemic to pulmonary
collaterals
Systemic vein

Pulmonary artery ≥4
vessels
Pulmonary vein

Stent placement

Systemic vein

RVOT
Aorta
Systemic artery (not aorta)

Ventricular septum
Pulmonary artery
Pulmonary vein
Systemic surgical shunt
Systemic pulmonary
collateral

Stent re-dilation

RVOT
Atrial septum
Aorta
Systemic artery (not aorta)
Systemic vein

Pulmonary artery
Pulmonary vein

Ventricular Septum

Snare foreign body
Transseptal puncture

Atrial septostomy
Recanalization of jailed vessel
in stent
Recanalization of occluded
vessel

Atrial septum dilation and
stent
Any catheterization <4 days
after surgery
Atretic valve perforation

Diagnostic Case
Valvuloplasty

Device or coil closure

Other

Venous Collateral
LSVC

Myocardial biopsy

Risk Category 4

Author Manuscript

Abbreviations: LSVC, left superior vena cava; ASD, atrial septal defect; PFO, patent foramen ovale; PDA, patent ductus arteriosus; RVOT, right
ventricular outflow tract; atm, atmospheres; CB, cutting balloon; VSD, ventricular septal defect
Data source: Bergersen L, Gauvreau K, Marshall A, et al. Circ Cardiovasc Inter. 2011; 4: 188-194.
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**

Systemic Saturation-- mean± s.d.

††

Single Ventricle Hemodynamic Data

Cardiac Index-- mean ± s.d.

Not used or electively initiated during procedure

In place at start of procedure

LVAD Use--no. (%)

#

Not used or electively initiated during procedure

In place at start of procedure

ECMO Use--no. (%)

84.1 ± 9.2

3.8 ± 1.4

4,450 (99.9)

3 (0.1)

4,436 (99.5)

21 (0.5)

62 (1.4)

¶

113 (2.6)

Started during case or used for measurement only

4,252 (96.0)

20 (0.5)

1,392 (31.3)

441 (9.9)

554 (12.4)

40.0 ± 34.8

On before case, on or off at end

No

Inotrope Need--no. (%)

Sepsis--no. (%)

Medical co-morbidities--no. (%)

Genetic Condition--no. (%)

Single Ventricle--no. (%)

Weight-- mean ± s.d.

*

1,969 (15.4)

Female Sex--no. (%)

2,163 (48.5)

1,462 (32.8)

>1 year to ≤ 18 years

>18 years

7,344 (57.4)

785 (17.6)
1,998 (44.8)

≥30 days to ≤1 year

83.9 ± 9.8

3.8 ± 1.3

12,708 (99.9)

19(0.1)

12,613 (99.1)

117 (0.9)

166 (1.3)

578 (4.5)

11,973 (94.1)

56 (0.4)

3,999 (31.3)

1,351 (10.6)

2,568 (20.1)

30.4 ± 29.3

6,040 (47.2)

2,650 (20.7)

215 (4.8)

824 (6.4)

≥150-300 cases/year n=12,787

<30 days

Age--no. (%)

<150 cases/year n=4,460

84.0 ± 10.6

3.8 ± 1.4

21,288 (99.9)

30 (0.1)

21,122 (99.0)

211 (1.0)

636 (3.0)

1,096 (5.2)

19,503 (91.8)

157 (0.7)

7,248 (33.9)

2,271 (10.6)

4,806 (22.5)

29.5 ± 28.3

9,989 (46.7)

3,074 (14.4)

12,716 (59.4)

4,238 (19.8)

1,363 (6.4)

≥300-500 cases/year n=21,391

Hospital Annual Volume

Baseline patient characteristics of study cohort stratified by annual hospital volume

83.6 ± 10.1

3.9 ± 1.3

17,756 (99.9)

25 (0.1)

17,608 (99.0)

179 (1.0)

573 (3.2)

963 (5.4)

16,181 (91.3)

88 (0.5)

5,539 (31.1)

2,135 (12.1)

3,272 (18.4)

28.4 ± 26.4

8,164 (45.8)

1,919 (10.8)

11,406 (64.0)

3,435 (19.3)

1,055 (5.9)

≥500 cases/year n=17,815

0.27

< 0.001

0.62

0.007

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

0.005

< 0.001

p-value
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¶¶

550 (12.3)
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2,836 (63.6)
979 (22.0)

No-- no. (%)

Missing-- no. (%)

3,278 (25.6)

7,753 (60.6)

4,426 (20.7)

13,775 (64.4)

3,190 (14.9)

2,751 (12.9)

16,243 (75.9)

2,397 (11.2)

1,640 (7.7)

14,096 (65.9)

5,655 (26.4)

7,827 (36.6)

12,615 (59.0)

949 (4.4)

31.1 ± 16.2

70.2 ± 9.6

94.4 ± 7.2

16.1 ± 7.3

61.9 ± 11.3

≥300-500 cases/year n=21,391

2,689 (15.1)

12,384 (69.5)

2,742 (15.4)

1864 (10.5)

13,850 (77.7)

2,101 (11.8)

1,675 (9.4)

11,738 (65.9)

4,402 (24.7)

6,425 (36.1)

10,397 (58.4)

993 (5.6)

31.7 ± 16.8

69.8 ± 9.5

94.8 ± 7.1

16.0 ± 6.9

61.3 ± 11.4

≥500 cases/year n=17,815

< 0.001

< 0.001

< 0.001

< 0.001

0.001

< 0.001

< 0.001

< 0.001

0.08

255 patients (18 from small, 35 from medium, 53 from large, 149 from very large volume programs) with missing information for genetic condition

239 patients (22 from small, 62 from medium, 115 from large, 40 from very large volume programs) with missing information for weight

90 patients (12 from small, 25 from medium, 26 from large, 27 from very large volume programs) with missing information for medical co-morbidities

‡

†

*

Abbreviations: no., number; s.d., standard deviation; ECMO, extracorporeal membrane oxygenation; LVAD, left ventricular assist device; MPA, main pulmonary artery; EDP, end diastolic pressure; MV,
mixed venous; SV, single ventricle; PA, pulmonary artery

645 (14.5)

Yes-- no. (%)

Pressure ≥17mmHg (SV)

PA Systolic Pressure ≥45 (non-SV) or Mean

1,756 (13.7)

2,175 (17.0)

710 (15.9)

No-- no. (%)

Missing-- no. (%)

9,275 (72.5)

452 (10.1)
3,298 (73.9)

Yes-- no. (%)

MV Saturation <60% (non-SV) or <50% (SV)
1,337 (10.5)

1,420 (11.1)

2,773 (62.2)

No-- no. (%)

Missing-- no. (%)

8,217 (64.3)

1,137 (25.5)

Yes-- no. (%)

3,150 (24.6)

4,920 (38.5)

1,556 (34.9)

Saturation <95% (non-SV) or <78% (SV)

Missing-- no. (%)

7,353 (57.5)

228 (5.1)
2,676 (60.0)

514 (4.0)

31.6 ± 16.4

70.4 ± 9.3

94.6 ± 6.9

14.9 ± 6.8

62.0 ± 11.2

No-- no. (%)

32.1 ± 16.6

70.5 ± 9.8

94.6 ± 6.9

15.9 ± 7.3

62.2 ± 11.4

≥150-300 cases/year n=12,787

Yes-- no. (%)

Systemic Ventricular EDP ≥ 18mmHg

MPA Systolic Pressure -- mean± s.d.

##

Mixed Venous Saturation-- mean± s.d.

Systemic Saturation-- mean± s.d.

∥∥

Non-Single Ventricle Hemodynamic Data

MPA Mean Pressure -- mean± s.d.

§§

Mixed Venous Saturation-- mean± s.d.

Author Manuscript

<150 cases/year n=4,460

p-value

Author Manuscript

Hospital Annual Volume

Jayaram et al.
Page 17

Author Manuscript
4,445 patients (516 from small, 1,217 from medium, 1,314 from large, 1,398 from very large volume programs) with missing information for non-SV systemic saturation

2,251 patients (123 from small, 608 from medium, 904 from large,616 from very large volume programs) with missing information for SV MPA Mean Pressure

9,121 patients (856 from small, 2,670 from medium, 3,522 from large, 2,073 from very large volume programs) with missing information for non-SV MPA Systolic Pressure

##

¶¶
6,128 patients (644 from small, 1,838 from medium, 2,147 from large, 1,499 from very large volume programs) with missing information for non-SV MV saturation

∥∥

§§

1,372 patients (66 from small, 337 from medium, 604 from large, 365 from very large volume programs) with missing information for SV MV saturation

‡‡

840patients (34 from small, 203 from medium, 326 from large, 277 from very large volume programs) with missing information for SV systemic saturation

††

11, 093 patients (1,098 from small, 3,270 from medium,4,033 from large, 2,692 from very large volume programs) with missing information for cardiac index

174 patients (7 from small, 60 from medium, 73 from large, 34 from very large volume programs) with missing information for LVAD use

**

#

146 patients (3 from small, 57 from medium,58 from large, 28 from very large volume programs) with missing information for ECMO use

¶

357 patients (33 from small, 70 from medium, 156 from large, 98 from very large volume programs) with missing information for inotrope need

899 patients (60 from small, 186 from medium, 389 from large, 264 from very large volume programs) with missing information for sepsis

Author Manuscript

∥

Author Manuscript

§
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61 (1.4)
2 (0.0)

Emergent

Salvage

Laryngeal Mask Airway
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199 (4.5)

Previously Intubated

840 (6.6)

165 (1.3)

9,193 (71.9)

836 (6.5)

4 (0.0)

165 (1.3)

1,920 (15.0)

12,137 (95.1)

96.5 ± 64.0

26 (0.2)

259 (2.0)

1,159 (9.1)

11,228 (88.6)

850 (6.6)

2,466 (19.3)

4,881 (38.2)

4,590 (35.9)

≥150-300 cases/year n=12,787

96 patients (7 from small, 27 from medium, 42 from large, 20 from very large volume programs) with missing information for Anesthesiologist present

‡

1,632 (9.2)

335 (1.9)

11,315 (63.5)

1,361 (7.6)

21 (0.1)

28 (0.2)

3,147 (17.7)

15,714 (88.3)

84.8 ± 66.4

27 (0.2)

503 (2.8)

2,435 (13.7)

14,797 (83.3)

1,372 (7.7)

3,391 (19.0)

4,562 (25.6)

8,490 (47.7)

≥500 cases/year n=17,815

313 patients (11 from small, 115 from medium, 134 from large, 53 from very large volume programs) with missing information for procedure status

1,497 (7.0)

223 (1.0)

15,598 (72.9)

1,330 (6.2)

14 (0.1)

19 (0.1)

2,690 (12.6)

20,247 (94.8)

92.0 ± 64.5

64 (0.3)

593 (2.8)

2,355 (11.1)

18,245 (85.8)

1,481 (6.9)

4,250 (19.9)

7,011 (32.8)

8,649 (40.4)

≥300-500 cases/year n=21,391

279 patients (26 from small, 72 from medium, 74 from large, 107 from very large volume programs) with missing information for procedure time

†

*

Abbreviations: no., number; s.d., standard deviation; CPAP, continuous positive airway pressure

45 (1.0)

Tracheostomy

2,931 (65.7)

3 (0.1)
144(3.2)

CPAP

Elective Intubation at case start

3 (0.1)

1,153 (25.9)

3,437 (77.2)

Bag Mask Ventilation

Spontaneous Respirations

Airway Management--no. (%)

Anesthesiologist Present--no. (%)

100.3 ± 61.6

480 (10.8)

Urgent

Procedure Time-- mean ± s.d.

3,906 (87.8)

Elective

‡

261 (5.9)

Risk Group 4

†

766 (17.2)

Risk Group 3

Procedure Status--no. (%)

1,883 (42.2)

Risk Group 2

*

1,550 (34.8)

Risk Group 1

Procedure-Type Risk Group--no. (%)

<150 cases/year n=4,460

Hospital Annual Volume

Baseline procedural characteristics of study cohort stratified by annual hospital volume

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

p-value

Author Manuscript
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†

36 (0.8)
9 (0.2)

††
‡‡

2 (0.0)

**

2 (0.0)
17 (0.4)

∥∥
60 (0.5)

3 (0.0)

12 (0.1)

54 (0.4)

2 (0.0)

22 (0.2)

2 (0.0)

7 (0.1)

4 (0.0)

7 (0.1)

1 (0.0)

66 (0.5)

198 (1.5)

≥150-300 cases/year n=12,787

112 (0.5)

10 (0.0)

20 (0.1)

114 (0.5)

5 (0.0)

57 (0.3)

25 (0.1)

16 (0.1)

7 (0.0)

28 (0.1)

6 (0.0)

155 (0.7)

431 (2.0)

≥300-500 cases/year n=21,391

Hospital Annual Volume
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4 patients (2 from large, 2 from very large volume programs) with missing information for new requirement for dialysis

¶

5 patients (2 from large,3 from very large volume programs) with missing information for embolic stroke

∥

4 patients (2 from large, 2 from very large volume programs) with missing information for air embolus

4 patients (2 from large, 2 from very large volume programs) with missing information for tamponade

§

‡

5 patients (1 from small, 2 from large, 2 from very large volume programs) with missing information for need for permanent pacemaker

†

2 patients (1 from large, 1 from very large volume programs) with missing information for cardiac arrest

*

Abbreviations: no., number; PPM, permanent pacemaker; ECMO, extracorporeal membrane oxygenation; LVAD, left ventricular assist device; cath, catheterization

38 (0.2)

4 (0.0)

11 (0.1)

32 (0.2)

2 (0.0)

45 (0.3)

7 (0.0)

4 (0.0)

8 (0.0)

24 (0.1)

5 (0.0)

136 (0.8)

262 (1.5)

≥500 cases/year n=17,815

Note: Individual adverse events do not add up to total adverse events because more than one adverse event could occur during a cath. lab visit

Subsequent Cardiac Cath.

Unplanned Other Surgery

§§

Unplanned Vascular Surgery

Unplanned Cardiac Surgery

Event Requiring LVAD

Event Requiring ECMO

12 (0.3)

8 (0.2)

5 (0.1)

#

¶

New Need for Dialysis

Embolic Stroke

∥

1 (0.0)

§

Air Embolus

Tamponade

11 (0.2)

4 (0.1)

41 (0.9)

123 (2.8)

‡

Arrhythmia (requiring PPM)

Cardiac Arrest

*

Major Adverse Events--no. (%)

<150 cases/year n=4,460

Author Manuscript

Frequency of adverse events stratified by annual hospital volume

< 0.001

0.51

0.05

< 0.001

0.50

0.34

< 0.001

0.06

0.86

0.01

0.05

0.02

< 0.001

p-value

Author Manuscript
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6 patients (1 from small, 2 from large, 3 from very large volume programs) with missing information for need for subsequent cardiac cath.

∥∥

6 (1 from small, 2 from large, 3 from very large volume programs) with missing information for need for other surgery

4 patients (1 from small, 1 from large, 2 from very large volume programs) with missing information for need for vascular surgery

§§

‡‡

3 patients (1 from small, 1 from large, 1 from very large volume programs) with missing information for need for cardiac surgery

††

4 patients (2 from large, 2 from very large volume programs) with missing information for need for LVAD

**

4 patients (2 from large, 2 from very large volume programs) with missing information for need for ECMO

Author Manuscript
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Adjusted Risk of Major Adverse Event
Primary Analysis (not including death)
Predictor

Odds Ratio (95% CI)

Secondary Analysis (including death)

P value

Odds Ratio (95% CI)

P value

Annual Volume
<150

Reference

Reference

150-<300

0.55 (0.35, 0.86)

0.008

0.82 (0.59, 1.14)

0.24

300-<500

0.62 (0.41, 0.95)

0.03

0.73 (0.53, 1.01)

0.06

≥500

0.52 (0.31, 0.90)

0.02

0.78 (0.52, 1.15)

0.21

Procedure-type risk group

Author Manuscript

1

Reference

Reference

2

1.31 (1.06, 1.62)

0.01

1.86 (1.44, 2.39)

<0.001

3

1.57 (1.26, 1.96)

<0.001

1.76 (1.35, 2.31)

<0.001

4

2.03 (1.59, 2.61)

<0.001

2.03 (1.50, 2.77)

<0.001

Age
<30 days

Reference

Reference

Author Manuscript

≥30 days to ≤1 year

0.98 (0.77, 1.25)

0.89

0.89 (0.71, 1.11)

0.31

1≤18 years

0.86 (0.66, 1.11)

0.24

0.69 (0.55, 0.88)

0.002

>18 years

0.94 (0.69, 1.29)

0.72

0.82 (0.62, 1.08)

0.16

Genetic/Congenital condition

1.05 (0.86, 1.28)

0.64

1.36 (1.15, 1.59)

<0.001

History of CLD

0.86 (0.67, 1.12)

0.27

1.79 (1.49, 2.15)

<0.001

History of Renal Insufficiency

2.32 (1.77, 3.04)

<0.001

3.16 (2.50, 4.01)

<0.001

Single Ventricle

1.34 (1.15, 1.56)

<0.001

1.39 (1.22, 1.60)

<0.001

Pre-procedure sepsis

1.43 (0.88, 2.31)

0.15

1.50 (0.95, 2.38)

0.08

Need for Inotropes

1.75 (1.43, 2.14)

<0.001

2.58 (2.16, 3.08)

<0.001

Need for ECMO

1.09 (0.77, 1.54)

0.63

5.79 (4.22, 7.93)

<0.001

Need for LVAD

0.81 (0.19, 3.43)

0.77

2.97 (0.96, 9.25)

0.06

Procedure Status
Elective

Reference

Reference

Urgent

2.14 (1.78, 2.58)

<0.001

2.99 (2.55, 3.50)

<0.001

Emergent

3.51 (2.69, 4.57)

<0.001

4.42 (3.47, 5.63)

<0.001

Salvage

5.85 (3.37, 10.14)

<0.001

21.80 (11.95, 39.79)

<0.001

Saturation <95% (non-SV) or <78% (SV)
No

Reference

Yes

1.13(0.96, 1.33)

0.15

1.13 (0.98, 1.31)

Reference
0.08

Missing

1.11 (0.87, 1.41)

0.39

1.00 (0.80, 1.26)

0.97

Author Manuscript

MV Saturation <60% (non-SV) or <50% (SV)
No

Reference

Yes

1.80 (1.49, 2.18)

<0.001

1.85 (1.58, 2.18)

Reference
<0.001

Missing

1.31 (1.04, 1.64)

0.02

1.65 (1.35, 2.02)

<0.001

MPA Systolic Pressure ≥45 (non-SV) or MPA Mean
Pressure ≥17mmHg (SV)
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Primary Analysis (not including death)

Author Manuscript

Predictor

Odds Ratio (95% CI)

P value

Secondary Analysis (including death)
Odds Ratio (95% CI)

P value

No

Reference

Reference

Yes

1.32 (1.09, 1.59)

0.004

1.99 (1.71, 2.32)

<0.001

Missing

1.42 (1.18, 1.71)

<0.001

1.27 (1.07, 1.51)

0.005

Systemic Ventricular EDP ≥ 18mmHg
No

Reference

Reference

Yes

1.48 (1.14, 1.94)

0.004

1.49 (1.18, 1.87)

<0.001

Missing

1.21 (1.04, 1.41)

0.02

1.13 (0.99, 1.30)

0.07

Abbreviations:CI, confidence interval; CLD, chronic lung disease; ECMO, extracorporeal membrane oxygenation; LVAD, left ventricular assist
device; SV, single ventricle; MV, mixed venous; MPA, main pulmonary artery; EDP, end diastolic pressure
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